Surescripts recruits from financial sector for new CEO

Harry Totonis has been named president and CEO of e-prescribing provider Surescripts, effective immediately.

The Alexandria, Va.-based Surescripts owns and operates a national e-prescribing network, connecting and enabling information sharing between U.S. physicians, pharmacies and payors.

As head of adviser services at MasterCard, Totonis expanded MasterCard into decision analytics and information-based products. He was responsible for a global team of business development and sales, products, technology development and customer delivery. With Booz Allen Hamilton, Totonis focused on strategy consulting for global companies across network-intensive sectors including technology, processing, consumer banking, insurance and airlines.

In the course of his 14 years with Booz Allen, he served in several executive positions, including managing partner of its global banking and insurance practice and as a member of its executive leadership team. Prior to MasterCard, as CEO of Kinexus, Totonis led the private banking network that enabled banks to share information and deliver financial advice to their customers.

Surescripts said that J.P. Little and Rick Ratliff, longtime senior executives and co-CEOs, are planning to stay with the company.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.